Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Journal of Virology|December 13, 2002
Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein CRegina M Kofler, Agnes Leitner, Gabriel O'Riordain, et al.Journal of Virology|July 16, 2004
Isolation of capsid protein dimers from the tick-borne encephalitis flavivirus and in vitro assembly of capsid-like particlesStefan Kiermayr, Regina M Kofler, Christian W Mandl, et al.Journal of Virology|September 15, 2007
Selection and analysis of mutations in an encephalomyocarditis virus internal ribosome entry site that improve the efficiency of a bicistronic flavivirus constructKlaus K Orlinger, Regina M Kofler, Franz X Heinz, et al.Vaccine|July 6, 2010
Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutationsPetra Schlick, Regina M Kofler, Beate Schittl, et al.Journal of Virology|July 30, 2003
Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell lineRainer Gehrke, Michael Ecker, Stephan W Aberle, et al.Journal of Virology|October 15, 2003
Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virusSteven L Allison, Yizhi J Tao, Gabriel O'Riordain, et al.Virology|June 6, 2008
Analysis of the effects of alterations in the tick-borne encephalitis virus 3'-noncoding region on translation and RNA replication using reporter repliconsVerena M Hoenninger, Harald Rouha, Klaus K Orlinger, et al.Proceedings of the National Academy of Sciences of the United States of America|February 11, 2004
Mimicking live flavivirus immunization with a noninfectious RNA vaccineRegina M Kofler, Judith H Aberle, Stephan W Aberle, et al.Journal of Virology|March 20, 2009
Helices alpha2 and alpha3 of West Nile virus capsid protein are dispensable for assembly of infectious virionsPetra Schlick, Christian Taucher, Beate Schittl, et al.Proceedings of the National Academy of Sciences of the United States of America|May 19, 2011
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titersKurt A Swanson, Ethan C Settembre, Christine A Shaw, et al.Pageof 4